论文部分内容阅读
目的观察并分析雾化剂(支气管扩张剂)在慢性阻塞性肺疾病稳定期的作用。方法选取2011年2月至2013年2月60例慢性阻塞性肺疾病患者作为观察对象,随机分为两组,对照组患者雾化吸入溴化异丙托品,观察组在此基础上加入沙丁胺醇,用药前后测定两组患者的基础肺功能,观察1秒用力呼气容积(FEV1)和用力肺活量(FVC),比较其药物应用效果。结果用药后观察组患者的FEV1及FVC的改善率明显高于对照组,差异有统计学意义(P<0.05),两组患者均未见明显不良反应。结论雾化吸入支气管扩张剂在慢性阻塞性肺疾病稳定期有良好的应用效果,联合应用的效果更明显。
Objective To observe and analyze the role of nebulizer (bronchodilator) in the stable phase of chronic obstructive pulmonary disease. Methods Sixty patients with chronic obstructive pulmonary disease from February 2011 to February 2013 were randomly divided into two groups. Patients in the control group were given ipratropium bromide inhalation, and the observation group was given salbutamol Before and after treatment, the basic lung function of the two groups was measured. The forced expiratory volume (FEV1) and forced vital capacity (FVC) of 1 second were observed to compare the effects of the drugs. Results The improvement rates of FEV1 and FVC in the observation group were significantly higher than those in the control group (P <0.05), and no significant adverse reactions were found in both groups. Conclusions The nebulized bronchodilator has a good application effect in the stable stage of chronic obstructive pulmonary disease, and the combined effect is more obvious.